CompuGroup Medical SE, DE0005437305

CompuGroup Medical SE, DE0005437305

09.08.2018 - 08:06:55

CompuGroup Medical SE Announces Results for the Second Quarter 2018

Koblenz, August 09, 2018: CompuGroup Medical SE (CGM) today published its financial report for the second quarter of 2018. The company, one of the world's leading providers of eHealth solutions, generated sales of EUR 190 million compared to EUR 140 million in the same period last year. EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to EUR 54 million compared to EUR 33 million in the second quarter of 2017. After a good start in the first quarter, the company continues to develop very positively across all business segments.

The business with ambulatory information systems is developing well internationally. In Germany, the further expansion of the telematics infrastructure (TI) is an important growth driver. The pharmacy software business was able to continue its strong start into 2018 with almost double-digit organic growth in the second quarter.

CGM SE's long-term strategy of consistently advancing the networking of all stakeholders in healthcare reached an important milestone with the approval of all necessary components of the telematics infrastructure at the end of last year. The now possible connection of all doctors and hospitals to a common secure data and communication network represents a decisive step towards modernizing and improving healthcare in Germany. To this end, CGM has in recent years invested a high double-digit million amount in research, development, and the technical and organizational preparation of the nationwide rollout of the TI. With the results in the second quarter, these investments are gradually beginning to pay off.

Frank Gotthardt, CEO of CompuGroup Medical SE, emphasizes: "We have kept our promise to connect all our customers to the telematics infrastructure quickly and in good time, thus equipping their practices for a modern and efficient healthcare system. The size of our efforts was never a question for us because we see it as a firm commitment to help our customers fulfill their legal obligations in terms of ambulatory information systems correctly and with the least possible effort. We are particularly proud that we have been able to connect more than 4,000 practices to the TI that are not CGM primary software customers. Our position as the only supplier of TI components with all approvals in place and also with the ability to deliver today has been achieved through numerous investments at many levels. This also enables us to take our responsibility beyond our own existing customer base. We have already successfully connected more than 50 different ambulatory information systems to the secure network and have thus proven that we are able to provide all physicians in Germany with access to the telematics infrastructure, regardless of the software they use. Many of our competitors in the market for ambulatory information software in Germany have also accepted our offer of a partnership in the development of the telematics infrastructure. In this way, we were able to put them in a position to support their customers in fulfilling this major new requirement.

Parallel to the rollout, we continue our investment in already planned software upgrades of the Connector and in numerous future applications in the telematics infrastructure. So CGM not only further improves the already available applications in the TI, but also raises the supply of new applications for the people in Germany to a new, modern level."

CompuGroup Medical confirms the forecast for the 2018 financial year published in the 2017 annual report. The company expects consolidated sales of EUR 700 million to EUR 730 million and a consolidated operating result (EBITDA) of between EUR 175 million and EUR 190 million.

 

Conference Call for Journalists, Investors and Analysts: The management board of CompuGroup Medical SE will go through the results at a conference for analysts and investors today at 15:00 hours CEST.

You can participate in this conference call by dialing one of the following phone numbers: +49 692 222 290 43 (Germany) +44 20 30 09 24 52 (UK) +1 855 40277 66 (USA)

Participant code: 66 28 70 42# A presentation will be available for download on cgm.com/PresentationQ2 prior to the conference call and can also be viewed live here.

About CompuGroup Medical SE

CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of more than EUR 580 million in 2017, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1 million users, including doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 19 countries and products in 55 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 4,600 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Editorial Staff Contact Information:

CompuGroup Medical SE Oliver Bruzek Chief Communication Officer T +49 (0) 261 8000-6100 F +49 (0) 261 8000-3100 E-Mail: press@cgm.com

09.08.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz

Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE0005437305 WKN: 543730 Indices: TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange   End of News DGAP News Service

712475  09.08.2018 

@ dgap.de